Steering clear of type 2 diabetes (T2D) has always been a smart move, since it also protects against health problems like ...

Biomea Fusion (BMEA) announced the presentation of new preclinical and clinical data for icovamenib, the company’s ...

A cure for diabetes has been top of mind for many that live with the conditions under the term’s umbrella. But type 1 diabetes, in particular, is an irreversible lifelong autoimmune condition. But new ...

Supercede Therapeutics, Inc., a startup biotech company focused on small molecule drug development, today announced preclinical efficacy data from its lead therapeutic program to treat obesity.